Abstract:Background: Although spinal opioids are safe and effective, pruritus is common and distressing. The authors previously demonstrated in mouse spinal cord that interactions between μ-opioid receptor isoform 1D and gastrin releasing peptide receptor mediate morphine-induced scratch. The C-terminal of 1D inhibits morphine-induced scratch without affecting analgesia. The authors hypothesize that human spinal cord also contains itch-specific μ-opioid receptor isoforms which interact with gastrin releasing peptide receptor. Methods: Reverse transcription polymerase chain reaction was performed on human spinal cord complimentary DNA from two human cadavers. Calcium responses to morphine (1 μM) were examined using calcium imaging microscopy on human cells (HEK293) coexpressing gastrin releasing peptide receptor and different human μ-opioid receptor isoforms. The authors assessed morphine-induced scratching behavior and thermal analgesia in mice following intrathecal injection of morphine (0.3 nmol) and a transactivator of transcription peptide designed from C-terminal sequences of 1Y isoform (0, 0.1, and 0.4 nmol). Results: The authors demonstrated 1Y expression in the spinal cord dorsal horn. Morphine administration evoked a calcium response (mean ± SD) (57 ± 13 nM) in cells coexpressing both gastrin releasing peptide receptor and the 1Y isomer. This was blocked by 10 μM naltrexone (0.7 ± 0.4 nM; P < 0.0001), 1 μM gastrin-releasing peptide receptor antagonist (3 ± 2 nM; P < 0.0001), or 200 μM 1Y-peptide (2 + 2 nM; P < 0.0001). In mice, 0.4 nmol 1Y-peptide significantly attenuated morphine-induced scratching behaviors (scratching bouts, vehicle vs. 1Y-peptide) (92 ± 31 vs. 38 ± 29; P = 0.011; n = 6 to 7 mice per group), without affecting morphine antinociception in warm water tail immersion test (% of maximum possible effect) (70 ± 21 vs. 67 ± 22; P = 0.80; n = 6 mice per group). Conclusions: Human μ-opioid receptor 1Y isomer is a C-terminal splicing variant of Oprm1 gene identified in human spinal cord. Cross-talk between 1Y and gastrin releasing peptide receptor is required for mediating opioid-induced pruritus. Disrupting the cross talk may have implications for therapeutic uncoupling of desired analgesic effects from side effects of opioids.

Desensitization to intrathecal substance P in mice: possible involvement of opioids

Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice

Intradermal hypertonic saline-induced behavior as a nociceptive test in mice

Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors

Intrathecal serotonin in mice: Analgesia and inhibition of a spinal action of substance P

Substance P Microinjected into the Periaqueductal Gray Matter Induces Antinociception and is Released Following Morphine Administration

Substance P Potentiates Thermal Hyperalgesia Induced by Intrathecal Administration of D-serine in Rats.

Transient tactile allodynia following intrathecal puncture in mouse: Contributions of Toll-like receptor signaling

The absence of endogenous β-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation

Sustained Potentiation by Substance P of NMDA-activated Current in Rat Primary Sensory Neurons

Interaction Between Substance P and Excitatory Amino Acid Receptors in Modulation of Nociceptive Responses of Cat Spinal Dorsal Horn Neurons.

Intrathecal injection of capsaicin can be used as a behavioural nociceptive test in mice

Context- and time-dependent neurobiological and behavioral sensitization induced by a single morphine exposure in mice

Alterations in the Substance P-induced Anti-Nociception in the Central Nervous System of Rats after Morphine Tolerance

Transcription and Protein Synthesis Inhibitors Reduce the Induction of Behavioural Sensitization to a Single Morphine Exposure and Regulate Hsp70 Expression in the Mouse Nucleus Accumbens.

Ketamine blocks enhancement of spinal long-term potentiation in chronic opioid treated rats

Analysis of the inflammatory response induced by substance P in the mouse pleural cavity

Cross-talk between Human Spinal Cord μ-opioid Receptor 1Y Isoform and Gastrin-releasing Peptide Receptor Mediates Opioid-induced Scratching Behavior

Possible Involvement of Toll-Like Receptor 4/myeloid Differentiation Factor-2 Activity of Opioid Inactive Isomers Causes Spinal Proinflammation and Related Behavioral Consequences

Spinal Serotonin-Ia and Ic/2-Receptors Mediate Supraspinal Mu-Opioid-Induced Analgesia

Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury